title: Diagnostic and therapeutic challenges.
authors.affiliation: Vitreous-Retina-Macula Consultants of New York, NY, USA.
authors.forename: Anton
authors.initials: A
authors.lastname: Orlin
authors.forename: R V Paul
authors.initials: RV
authors.lastname: Chan
authors.forename: K Bailey
authors.initials: KB
authors.lastname: Freund
authors.forename: James C
authors.initials: JC
authors.lastname: Folk
authors.forename: Felix
authors.initials: F
authors.lastname: Chau
authors.forename: Debra A
authors.initials: DA
authors.lastname: Goldstein
mesh_terms: D000328:Adult; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D004396:Coloring Agents; D003937:Diagnosis, Differential; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007208:Indocyanine Green; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D000069579:Ranibizumab; D012008:Recurrence; D012164:Retinal Diseases / Q000175:diagnosis* / Q000188:drug therapy; D041623:Tomography, Optical Coherence; D014786:Vision Disorders / Q000175:diagnosis* / Q000188:drug therapy; D014792:Visual Acuity
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D004396:Coloring Agents; D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid; D007208:Indocyanine Green; D000069579:Ranibizumab